Company Filing History:
1 out of 3 
1 out of 2 
1 out of 1 Years Active: 2017
Title: Rafal Tomecki: Innovator in Cancer Treatment
Introduction
Rafal Tomecki is a notable inventor based in Warsaw, Poland. He has made significant contributions to the field of cancer treatment through his innovative research and patented methods. His work focuses on the development of therapeutic agents that target specific cancer mutations.
Latest Patents
Rafal Tomecki holds a patent for a method titled "Method for selection of hDIS3 PIN domain inhibitors and use of hDIS3 PIN domain inhibitors for cancer treatment." This invention relates to a method for selecting or screening hDIS3 PIN domain inhibitors, as well as the yeast strain and cell line used in such methods. The patent also discusses new therapeutic agents selected as hDIS3 PIN domain inhibitors and their applications in treating cancers with mutations in the hDIS3 RNB domain, particularly multiple myeloma. Additionally, the invention includes a composition comprising the new therapeutic agent hDIS3 PIN domain inhibitor and a method for inducing synthetic lethality in cancer cells.
Career Highlights
Throughout his career, Rafal Tomecki has worked with esteemed organizations such as the Institute of Biochemistry and Biophysics of the Polish Academy of Sciences and Oncoarendi Therapeutics Sp. z o.o. His experience in these institutions has allowed him to advance his research and contribute to the scientific community.
Collaborations
Rafal has collaborated with notable colleagues, including Andrzej Dziembowski and Karolina Drazkowska. These partnerships have further enriched his research endeavors and have played a crucial role in his innovative work.
Conclusion
Rafal Tomecki is a distinguished inventor whose work in cancer treatment showcases the potential of targeted therapies. His patented methods and collaborations highlight his commitment to advancing medical science and improving patient outcomes.